EverEx
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EverEx - overview
Established
2019
Location
Seoul, -, South Korea
Primary Industry
Healthcare IT
About
Based in Seoul, South Korea, and founded in 2019, EverEx operates as a digital healthcare company offering a medical platform for musculoskeletal disorder consultation. The company’s platform has over 3000 rehabilitation exercises available in its platform. In November 2025, EverEx raised KRW 4 billion in series B funding from Daewoong Investment and Naver. The round was part of a larger KRW 18.
8 billion series B funding. The firm as of November 2025, is led by its founder and CEO, Chan Yoon. The company offers artificial intelligence (AI) technology and evidence-based treatment and exercise therapy for musculoskeletal diseases, which is a painful chronic conditions affecting muscles, tissues, and joints. The company’s solutions include MORA, a mobile treatment curriculum providing rehabilitation and exercise treatment solution, and a self-developed AI posture estimation technology, that recognizes the exercise motions of the patients through smartphone cameras and evaluates joint functions.
EverEx also allows medical staff of hospitals, clinics, and domestic companies to prescribe rehabilitation, and manage and monitor patients remotely. The company will use the November 2025 funding to collaborate with Daewoong Pharmaceutical for domestic distribution and to expedite the commercialization of its products.
Current Investors
WOORI Venture Partners, Premier Partners, Samsung NEXT Ventures
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software
Website
www.everex.kr
Verticals
Artificial Intelligence, HealthTech, Mobile Apps
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.